A carregar...

Customization of therapy for gastroesophageal adenocarcinoma patients

Gastroesophageal adenocarcinomas (GEACs) remain a global health problem. These are most often diagnosed at advanced stage and the estimated 5-year relative survival rate is about 5%. Although cure is not possible for patients with advanced GEAC, systemic therapy (chemotherapy or biochemotherapy) can...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chronic Dis Transl Med
Main Authors: Mizrak Kaya, Dilsa, Harada, Kazuto, Amlashi, Fatemeh G., Vasilakopoulou, Maria, Ajani, Jaffer A.
Formato: Artigo
Idioma:Inglês
Publicado em: Chinese Medical Association 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5938285/
https://ncbi.nlm.nih.gov/pubmed/29756119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cdtm.2018.02.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!